Enantioselective Pharmacokinetics of dl-threo-Methylphenidate in Humans

Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists

Volumn 10, Issue 1, 1993, Pages 14-21

  Srinivas, Nuggehally R ^a,b   Hubbard, John W ^a   Korchinski, Elarien D ^a   Midha, Kamal K ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b BRISTOL MYERS SQUIBB COMPANY   (United States)

Author keywords

dl threo methylphenidate; enantioselective pharmacokinetics; immediate release methylphenidate; intravenous methylphenidate; slow release methylphenidate

Indexed keywords

METHYLPHENIDATE;

ADULT; ARTICLE; BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM; DRUG EXCRETION; DRUG METABOLISM; ENANTIOMER; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; SUSTAINED RELEASE PREPARATION; VOLUNTEER;

ADMINISTRATION, ORAL; ADULT; BIOLOGICAL AVAILABILITY; COMPARATIVE STUDY; DELAYED-ACTION PREPARATIONS; HALF-LIFE; HUMAN; INJECTIONS, INTRAVENOUS; MALE; METHYLPHENIDATE; STEREOISOMERISM; SUPPORT, NON-U.S. GOV'T;

EID: 0027525916     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1023/A:1018956526016     Document Type: Article

References (37)

1. Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology
2. Chiral pharmacology and its consequences for therapeutic monitoring
3. The pharmacological and toxicological significance of the stereochemistry of drug disposition
4. Problems in therapeutic drug monitoring: The dilemma of enantiomeric drugs in man
5. Importance of drug enantiomers in clinical pharmacology
6. Short-term effects of methylphenidate on the cognitive, learning and academic performance of children with attention deficit disorder in the laboratory and the classroom
7. Comparison of sustained release and standard methylphenidate in the treatment of minimal brain dysfunction
8. Metabolism and disposition of methylphenidate-14C: Studies in man and animals
9. Two new metabolites of methylphenidate
10. Metabolism of methylphenidate in dog and rat
11. A comparison of the capacities of isomers of amphetamine, deoxypipradol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta
12. Comparison of the effects of the isomers of amphetamine, methylphenidate and deoxypipradol on the uptake of 1-[3H]-norepinephrine and [3H]-dopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus
13. Conformational similarities between molecular models of phenethylamine and of potent inhibitors of the uptake of tritiated norepinephrine by adrenergic nerves in rabbit aorta
14. Pharmacology of the enantiomers of threo-methylphenidate
15. Stereoselective disposition of methylphenidate in children with attention-deficit disorder
16. Development of enantioselective gas chromatographic quantitation assay for dlthreo-methylphenidate in biological fluids
17. Gas chromatographicmass spectrometric analysis of threo-methylphenidate enantiomers in plasma
18. Kinetic analysis of enantiomers of threo-methylphenidate and its metabolite in two healthy subjects after oral administration as determined by a gas chromatographic-mass spectrometric method
19. Enantioselective aspects of the disposition of dl- threo-methylphenidate after the administration of a sustained-release formulation to children with attention deficit-hyperactivity disorder
20. Enantioselective gas chromatographic assay with electron capture detection for dl-ritalinic acid in plasma
21. Slow-release methylphenidate: Problems when children chew tablets
22. Attention deficit disorder with hyperactivity: Differential effects of methylphenidate on impulsivity
23. Components of attention, methylphenidate dosage and blood levels in children with attention deficit disorder
24. Effects of methylphenidate dosage in hyperactive reading-disabled children. I. Behaviour and cognitive performance effects
25. Methylphenidate and dose plasma concentrations and behavioural response in children
26. Pharmacokinetics of methylphenidate in man, rat and monkey
27. Psychopharmacology of attention deficit disorder: Pharmacokinetic, neuroendocrine and behavioural measures following acute and chronic treatment with methylphenidate
28. Stereoselective urinary pharmacokinetics of dl-threo-methylphenidate and its major metabolite in humans
29. Distribution of methylphenidate and p-hydroxymethylphenidate in rats
30. Pharmacokinetics of methylphenidate in the rat using single-ion monitoring GLC-mass spectrometry
31. Pharmacokinetics of methylphenidate in hyperkinetic children
32. The absorption of sustained-release methylphenidate formulations compared to an immediate-release formulation
33. Methylphenidate hydrochloride given with or before breakfast. II. Effects on plasma concentrations of methylphenidate and ritalinic acid
34. Sustained release methylphenidate: Pharmacokinetic studies in ADDH males